Literature DB >> 8109911

Campylobacter jejuni and Guillain-Barré syndrome.

J H Rees, R A Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8109911     DOI： 10.1002/ana.410350228

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

1.  Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.

Authors:  M M Prendergast; T U Kosunen; A P Moran
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Differentiation of Campylobacter jejuni serotype O19 strains from non-O19 strains by PCR.

Authors:  N Misawa; B M Allos; M J Blaser
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

3.  Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.

Authors:  M M Prendergast; A J Lastovica; A P Moran
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Guillain-Barré syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype.

Authors:  Sonja E Leonhard; Cristiane C Bresani-Salvi; Joanna D Lyra Batista; Sergio Cunha; Bart C Jacobs; Maria Lucia Brito Ferreira; Maria de Fatima P Militão de Albuquerque
Journal:  PLoS Negl Trop Dis       Date:  2020-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.